Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABL-101 and 19F-MRI for Mapping Carotid Plaque Inflammation
NCT06850324Phase 2Not yet recruiting
- Start
- Jul 2025
- Primary completion
- Jun 2027
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perfluoro-tert-butylcyclohexane in carotid atheroma (CAS). Planned start Jul 2025; status: not yet recruiting.
02
Drugs
perfluoro-tert-butylcyclohexane
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on NCT06850324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06850324.